Robert J. Motzer - Researcher Profile

Publications

3 shown

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer , Nizar M. Tannir , Ray McDermott +29 more

Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...

2018 New England Journal of Medicine 4403 citations

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert M. Samstein , Chung‐Han Lee , Alexander N. Shoushtari +54 more

2019 Nature Genetics 4163 citations

Expression of Basic Fibroblast Growth Factor in Primary Human Renal Tumors: Correlation With Poor Survival

David M. Nanus , Bernd J. Schmitz‐Dräger , Robert J. Motzer +5 more

Journal Article Expression of Basic Fibroblast Growth Factor in Primary Human Renal Tumors: Correlation With Poor Survival Get access David M. Nanus, David M. Nanus Laboratory o...

1993 JNCI Journal of the National Cancer I... 128 citations

Frequent Co-Authors

Nizar M. Tannir

The University of Texas MD Anderson Cancer Center

Ray McDermott

Researcher Info

h-index: 3
Publications: 3
Citations: 8,694
Institution: Memorial Sloan Kettering Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-6925-2327

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.